Cambridge Biotechnology - Ownership and Business Overview

Life ScienceCompany

Cambridge Biotechnology Ownership

Who owns Cambridge Biotechnology?

Cambridge Biotechnology is owned by Swedish Orphan Biovitrum AB. It was acquired on March 21, 2005.

Cambridge Biotechnology Business Overview

Where is Cambridge Biotechnology headquartered?

Cambridge Biotechnology is headquartered in Cambridge, United Kingdom.

What sector is Cambridge Biotechnology in?

Cambridge Biotechnology is a life science company.

When was Cambridge Biotechnology founded?

Cambridge Biotechnology was founded in 2001.

Life Science M&A Summary in 2005

Out of 60 sectors in the Mergr database, life science ranked 15 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.

Join Mergr to view all 77 acquisitions of life science companies in 2005, including 17 acquisitions by private equity firms, and 60 by strategics.

Cambridge Biotechnology Ltd.

Babraham Research Campus Building 250,
Cambridge, CB22 3AT
United Kingdom,
44 1223 497300

Cambridge Biotechnology Ltd. is a Cambridge UK based private drug discovery company. CBT's drug discovery efforts have been focused on obesity, pain and inflammation, utilizing the company's top class scientific and technical skills in the field of cytokine receptors.

 Subscribe to unlock this and 203,291
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Cambridge Biotechnology

Life Science Companies , United Kingdom Companies